International Journal of Celiac Disease · 2016 · 23 citations · 34 references
Life SciencesImmunologyInternal MedicineAutoimmunityClinical ImmunologyImmunopathologyAntigen Detection AssaysAutoantibodiesAutoantigensAutoimmune Disease DiagnosticsAutoimmune DiseasesCeliac DiseaseAnti-transglutaminase AntibodiesAntibodiesAutoantibody AssaysCeliac Disease ImmunologyCeliac Disease SerologyCeliac Serology
Detection of IgA-transglutaminase2 (TG2) autoantibodies has become the test of choice for the diagnosis and monitoring of celiac disease (CD), and is recommended as the serological âgold standardâ by most of the CD societies. Despite its wide acceptance and reasonable performance, several aspects are problematic and disputed. The normal range levels between positivity and negativity are modified, manufacturersâ cut-off levels are extremely variable, far from matching in house determinations, insufficient standardization, inadequate reference protocols and no reliable quality assessment of the ELISA antibody (AB) kits for CD diagnosis and follow-up of dietary adherence. Numerous limitations exist in its detection, diagnosis, and follow-up capacities, resulting in frequent clinical circumstances when professionals encounter false positive and negative situations. The present review updates and discusses these facets and aims to extend our knowledge and help CD associated professionals to use the IgA-TG2 antibodies appropriately. We hope that the content of the review will stimulate the scientific community to explore and better delineate the role and functions of the AB and the industrial manufacturers to improve clinical performance of their diagnostic tests.
34
Steffen Husby, Sibylle Koletzko, Ilma R. Korponay‐Szabó et al. · Journal of Pediatric Gastroenterology and Nutrition · 2011 · 2.7K citations · Full text
Medicine, Nutrition, Pediatrics +17